Anti-Neoplastic Therapy and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Anti-Neoplastic Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Neoplastic Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Neoplastic Therapy Overall Market Size
2.1 Global Anti-Neoplastic Therapy Market Size: 2022 VS 2029
2.2 Global Anti-Neoplastic Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-Neoplastic Therapy Players in Global Market
3.2 Top Global Anti-Neoplastic Therapy Companies Ranked by Revenue
3.3 Global Anti-Neoplastic Therapy Revenue by Companies
3.4 Top 3 and Top 5 Anti-Neoplastic Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-Neoplastic Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Neoplastic Therapy Players in Global Market
3.6.1 List of Global Tier 1 Anti-Neoplastic Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-Neoplastic Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Neoplastic Therapy Market Size Markets, 2022 & 2029
4.1.2 Chemotherapeutic Agents
4.1.3 Immunotherapeutic Agents
4.1.4 Personalized Medicine
4.2 By Type - Global Anti-Neoplastic Therapy Revenue & Forecasts
4.2.1 By Type - Global Anti-Neoplastic Therapy Revenue, 2018-2023
4.2.2 By Type - Global Anti-Neoplastic Therapy Revenue, 2024-2029
4.2.3 By Type - Global Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Neoplastic Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Cancer Rehabilitation Centers
5.1.5 Ambulatory Surgical Centers
5.2 By Application - Global Anti-Neoplastic Therapy Revenue & Forecasts
5.2.1 By Application - Global Anti-Neoplastic Therapy Revenue, 2018-2023
5.2.2 By Application - Global Anti-Neoplastic Therapy Revenue, 2024-2029
5.2.3 By Application - Global Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Neoplastic Therapy Market Size, 2022 & 2029
6.2 By Region - Global Anti-Neoplastic Therapy Revenue & Forecasts
6.2.1 By Region - Global Anti-Neoplastic Therapy Revenue, 2018-2023
6.2.2 By Region - Global Anti-Neoplastic Therapy Revenue, 2024-2029
6.2.3 By Region - Global Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anti-Neoplastic Therapy Revenue, 2018-2029
6.3.2 US Anti-Neoplastic Therapy Market Size, 2018-2029
6.3.3 Canada Anti-Neoplastic Therapy Market Size, 2018-2029
6.3.4 Mexico Anti-Neoplastic Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anti-Neoplastic Therapy Revenue, 2018-2029
6.4.2 Germany Anti-Neoplastic Therapy Market Size, 2018-2029
6.4.3 France Anti-Neoplastic Therapy Market Size, 2018-2029
6.4.4 U.K. Anti-Neoplastic Therapy Market Size, 2018-2029
6.4.5 Italy Anti-Neoplastic Therapy Market Size, 2018-2029
6.4.6 Russia Anti-Neoplastic Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Anti-Neoplastic Therapy Market Size, 2018-2029
6.4.8 Benelux Anti-Neoplastic Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anti-Neoplastic Therapy Revenue, 2018-2029
6.5.2 China Anti-Neoplastic Therapy Market Size, 2018-2029
6.5.3 Japan Anti-Neoplastic Therapy Market Size, 2018-2029
6.5.4 South Korea Anti-Neoplastic Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Anti-Neoplastic Therapy Market Size, 2018-2029
6.5.6 India Anti-Neoplastic Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anti-Neoplastic Therapy Revenue, 2018-2029
6.6.2 Brazil Anti-Neoplastic Therapy Market Size, 2018-2029
6.6.3 Argentina Anti-Neoplastic Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-Neoplastic Therapy Revenue, 2018-2029
6.7.2 Turkey Anti-Neoplastic Therapy Market Size, 2018-2029
6.7.3 Israel Anti-Neoplastic Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-Neoplastic Therapy Market Size, 2018-2029
6.7.5 UAE Anti-Neoplastic Therapy Market Size, 2018-2029
7 Anti-Neoplastic Therapy Companies Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Anti-Neoplastic Therapy Major Product Offerings
7.1.4 Amgen Inc. Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.1.5 Amgen Inc. Key News & Latest Developments
7.2 AstraZeneca plc
7.2.1 AstraZeneca plc Company Summary
7.2.2 AstraZeneca plc Business Overview
7.2.3 AstraZeneca plc Anti-Neoplastic Therapy Major Product Offerings
7.2.4 AstraZeneca plc Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca plc Key News & Latest Developments
7.3 Bayer AG
7.3.1 Bayer AG Company Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Anti-Neoplastic Therapy Major Product Offerings
7.3.4 Bayer AG Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.3.5 Bayer AG Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Anti-Neoplastic Therapy Major Product Offerings
7.4.4 Johnson & Johnson Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc. Company Summary
7.5.2 Merck & Co., Inc. Business Overview
7.5.3 Merck & Co., Inc. Anti-Neoplastic Therapy Major Product Offerings
7.5.4 Merck & Co., Inc. Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.5.5 Merck & Co., Inc. Key News & Latest Developments
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Company Summary
7.6.2 Pfizer Inc. Business Overview
7.6.3 Pfizer Inc. Anti-Neoplastic Therapy Major Product Offerings
7.6.4 Pfizer Inc. Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.6.5 Pfizer Inc. Key News & Latest Developments
7.7 F. Hoffmann-La Roche Ltd.
7.7.1 F. Hoffmann-La Roche Ltd. Company Summary
7.7.2 F. Hoffmann-La Roche Ltd. Business Overview
7.7.3 F. Hoffmann-La Roche Ltd. Anti-Neoplastic Therapy Major Product Offerings
7.7.4 F. Hoffmann-La Roche Ltd. Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.7.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Company Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Anti-Neoplastic Therapy Major Product Offerings
7.8.4 Eli Lilly and Company Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly and Company Key News & Latest Developments
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Anti-Neoplastic Therapy Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Ltd. Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Company Summary
7.10.2 Boehringer Ingelheim Business Overview
7.10.3 Boehringer Ingelheim Anti-Neoplastic Therapy Major Product Offerings
7.10.4 Boehringer Ingelheim Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.10.5 Boehringer Ingelheim Key News & Latest Developments
7.11 Aspen Pharmacare Holdings Limited
7.11.1 Aspen Pharmacare Holdings Limited Company Summary
7.11.2 Aspen Pharmacare Holdings Limited Business Overview
7.11.3 Aspen Pharmacare Holdings Limited Anti-Neoplastic Therapy Major Product Offerings
7.11.4 Aspen Pharmacare Holdings Limited Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.11.5 Aspen Pharmacare Holdings Limited Key News & Latest Developments
7.12 AbbVie Inc.
7.12.1 AbbVie Inc. Company Summary
7.12.2 AbbVie Inc. Business Overview
7.12.3 AbbVie Inc. Anti-Neoplastic Therapy Major Product Offerings
7.12.4 AbbVie Inc. Anti-Neoplastic Therapy Revenue in Global Market (2018-2023)
7.12.5 AbbVie Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Anti-Neoplastic Therapy Market Opportunities & Trends in Global Market
Table 2. Anti-Neoplastic Therapy Market Drivers in Global Market
Table 3. Anti-Neoplastic Therapy Market Restraints in Global Market
Table 4. Key Players of Anti-Neoplastic Therapy in Global Market
Table 5. Top Anti-Neoplastic Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-Neoplastic Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-Neoplastic Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-Neoplastic Therapy Product Type
Table 9. List of Global Tier 1 Anti-Neoplastic Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Neoplastic Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Neoplastic Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti-Neoplastic Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-Neoplastic Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Anti-Neoplastic Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti-Neoplastic Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-Neoplastic Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Anti-Neoplastic Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti-Neoplastic Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-Neoplastic Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-Neoplastic Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-Neoplastic Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-Neoplastic Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-Neoplastic Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-Neoplastic Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Inc. Company Summary
Table 31. Amgen Inc. Anti-Neoplastic Therapy Product Offerings
Table 32. Amgen Inc. Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Inc. Key News & Latest Developments
Table 34. AstraZeneca plc Company Summary
Table 35. AstraZeneca plc Anti-Neoplastic Therapy Product Offerings
Table 36. AstraZeneca plc Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca plc Key News & Latest Developments
Table 38. Bayer AG Company Summary
Table 39. Bayer AG Anti-Neoplastic Therapy Product Offerings
Table 40. Bayer AG Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Bayer AG Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Anti-Neoplastic Therapy Product Offerings
Table 44. Johnson & Johnson Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Merck & Co., Inc. Company Summary
Table 47. Merck & Co., Inc. Anti-Neoplastic Therapy Product Offerings
Table 48. Merck & Co., Inc. Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Merck & Co., Inc. Key News & Latest Developments
Table 50. Pfizer Inc. Company Summary
Table 51. Pfizer Inc. Anti-Neoplastic Therapy Product Offerings
Table 52. Pfizer Inc. Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Inc. Key News & Latest Developments
Table 54. F. Hoffmann-La Roche Ltd. Company Summary
Table 55. F. Hoffmann-La Roche Ltd. Anti-Neoplastic Therapy Product Offerings
Table 56. F. Hoffmann-La Roche Ltd. Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 58. Eli Lilly and Company Company Summary
Table 59. Eli Lilly and Company Anti-Neoplastic Therapy Product Offerings
Table 60. Eli Lilly and Company Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Eli Lilly and Company Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Ltd. Company Summary
Table 63. Teva Pharmaceutical Industries Ltd. Anti-Neoplastic Therapy Product Offerings
Table 64. Teva Pharmaceutical Industries Ltd. Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 66. Boehringer Ingelheim Company Summary
Table 67. Boehringer Ingelheim Anti-Neoplastic Therapy Product Offerings
Table 68. Boehringer Ingelheim Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Boehringer Ingelheim Key News & Latest Developments
Table 70. Aspen Pharmacare Holdings Limited Company Summary
Table 71. Aspen Pharmacare Holdings Limited Anti-Neoplastic Therapy Product Offerings
Table 72. Aspen Pharmacare Holdings Limited Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Aspen Pharmacare Holdings Limited Key News & Latest Developments
Table 74. AbbVie Inc. Company Summary
Table 75. AbbVie Inc. Anti-Neoplastic Therapy Product Offerings
Table 76. AbbVie Inc. Anti-Neoplastic Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. AbbVie Inc. Key News & Latest Developments
List of Figures
Figure 1. Anti-Neoplastic Therapy Segment by Type in 2022
Figure 2. Anti-Neoplastic Therapy Segment by Application in 2022
Figure 3. Global Anti-Neoplastic Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Neoplastic Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Neoplastic Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Neoplastic Therapy Revenue in 2022
Figure 8. By Type - Global Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti-Neoplastic Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti-Neoplastic Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
Figure 16. US Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
Figure 28. China Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti-Neoplastic Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti-Neoplastic Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Inc. Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca plc Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bayer AG Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Merck & Co., Inc. Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Inc. Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. F. Hoffmann-La Roche Ltd. Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eli Lilly and Company Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Pharmaceutical Industries Ltd. Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Boehringer Ingelheim Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Aspen Pharmacare Holdings Limited Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. AbbVie Inc. Anti-Neoplastic Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)